Company / Total Assets
Cue Biopharma, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$42.2M
FY2025
5-year range
$32.2M / $91.3M
FY2021-FY2025
Trend
+31.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $42M.
Based on SEC 10-K filings.
$42M in FY2025 with a 5-year CAGR of -15.8%.
Declined from $62M to $42M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -22.7%
- 5-Year CAGR
- -15.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.8%, indicating a declining trend.
- In FY2025, total assets increased 31.1% year-over-year.
- Peak total assets was recorded in FY2020.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.2M | +31.1% |
| FY2024 | $32.2M | -47.7% |
| FY2023 | $61.5M | -32.6% |
| FY2022 | $91.3M | +9.5% |
| FY2021 | $83.4M | -16.2% |
| FY2020 | $99.5M | +39.0% |
| FY2019 | $71.6M | +57.8% |
| FY2018 | $45.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026